| Name: | Clarithromycin EP Impurity C |
| Catalogue No. | VL740001 |
| CAS No. | 127253-06-9 |
| Molecular Formula | C38H70N2O13 |
| Molecular Weight | 762.97 |
| Status | In-stock |
| IUPAC Name | 6-O-Methylerythromycin A (E)-9-oxime |
| Synonyms | Clarithromycin 9-Oxim |
| Appearance | White solid |
| Description | Clarithromycin EP Impurity C (CAS No: 127253-06-9) or Clarithromycin 9-Oxime is an oxime derivative of Erythromycin. Erythromycin is a macrolide that functions by blocking the translocation reaction at the time of protein synthesis. Erythromycin, except under alkaline conditions, is inactive against the Enterobacteriaceae and Pseudomonas aeruginosa. |
| References | Master, Hosang, and Singh Dharmendra. “A Regioselective Alkylation at the C-6 Hydroxyl Group of Erythromycin A-Oxime Derivatives.” Journal of the Serbian Chemical Society, vol. 70, no. 10, 2005, pp. 1147–54, https://doi.org/10.2298/jsc0510147m. WASHINGTON, JOHN A., and WALTER R. WILSON. “Erythromycin: A Microbial and Clinical Perspective after 30 Years of Clinical Use (First of Two Parts).” Mayo Clinic Proceedings, vol. 60, no. 3, Mar. 1985, pp. 189–203, https://doi.org/10.1016/s0025-6196(12)602 |
